Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer

Based on single agent activities and the additive or synergistic effects of three individual drugs in gastric cancer, we performed a phase II study of a new regimen combining epirubicin, docetaxel and cisplatin (EDP) for unresectable gastric cancer. The patients with histologically confirmed metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, S-H, Kang, W K, Park, J, Kim, H Y, Kim, J H, Lee, S I, Park, J O, Kim, K, Jung, C W, Park, Y S, Im, Y-H, Lee, M H, Park, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364756/
https://www.ncbi.nlm.nih.gov/pubmed/15188010
http://dx.doi.org/10.1038/sj.bjc.6601891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364756/
https://www.ncbi.nlm.nih.gov/pubmed/15188010
http://dx.doi.org/10.1038/sj.bjc.6601891

Ejemplares similares